Maiva Pharma Private Limited
Indian Pharmaceutical Exporter ยท Cardiovascular Specialist ยท $4.5M Total Trade ยท DGFT Verified
Maiva Pharma Private Limited is an Indian pharmaceutical exporter with a total trade value of $4.5M across 4 products in 4 therapeutic categories. Based on 92 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Diltiazem ($2.3M), Furosemide ($1.6M), Ephedrine ($350.0K).
Maiva Pharma Private Limited โ Export Portfolio & Destination Treemap

Who is Maiva Pharma Private Limited? โ Company Overview & Market Position
Maiva Pharma Private Limited, established on February 5, 1993, is a privately held pharmaceutical company headquartered in Bangalore North, Karnataka, India. The company operates under the Corporate Identification Number (CIN) U24231KA1993PTC013976 and is registered with the Registrar of Companies, Bangalore. As of the latest available data, Maiva Pharma has an authorized capital of โน310.3 million and a paid-up capital of โน138.4 million.
In the fiscal year ending March 31, 2025, Maiva Pharma reported a total revenue of โน1,000 million, marking a 28.82% increase from the previous year. The company's net worth also saw a significant rise of 36.72% during the same period. The workforce comprises approximately 751 professionals, reflecting the company's substantial operational scale. Maiva Pharma's official website is www.maivapharma.com.